EPM
JSPRW icon

Equitec Proprietary Markets’s Japer Therapeutics Warrants JSPRW Stock Holding History

Equitec Proprietary Markets’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-33,586
Closed -$4.13K – 133
2023
Q2 		$4.13K Sell
33,586
-11,270
-25% -$1.74K ﹤0.01% 81
2023
Q1 		$8.97K Sell
44,856
-1,000
-2% -$146 ﹤0.01% 91
2022
Q4 		$1.38K Hold
45,856
– – ﹤0.01% 167
2022
Q3 		$3K Hold
45,856
– – ﹤0.01% 207
2022
Q2 		$4K Hold
45,856
– – ﹤0.01% 208
2022
Q1 		$12K Hold
45,856
– – ﹤0.01% 169
2021
Q4 		$67K Buy
+45,856
New +$63.9K 0.01% 197

Other funds holding JSPRW

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return